Cipla

Cipla Q2 net profit rises 7.6% to Rs712 cr, revenues up 9.6% at Rs5,519.8 cr

28 Oct 2021

Cipla to set up manufacturing facility in Iran in JV with Ahran Tejarat

15 Dec 2016

Cipla to sell entire 16.7% stake in US-based Chase Pharmaceuticals to Allergan Plc

24 Nov 2016

Cipla Q3 net profit up 4.7% at Rs343 cr

10 Feb 2016

Cipla appoints HSBC's Naina Lal Kidwai as independent director

10 Nov 2015

Cipla Medpro, Serum Institute team up to provide vaccines in South Africa

09 Oct 2015

Cipla to acquire 100% stake in two US generic drug firms for $550 mn

04 Sep 2015

Cipla, a global major in generic pharmaceuticals, today announced the acquisition of two US-based generic drug companies,aimed at strengthening its marketing network

Leave drug pricing to fair competition, Cipla chief tells govt

28 Aug 2015

Cipla to buy Brazil’s Duomed Produtos Farmaceuticos for Rs2.6 cr

09 Apr 2015

Cipla appeals HC order barring sales of cheap lung drug

14 Jan 2015

HC backs Novartis, bars Cipla from selling lung drug copy

By By Jagdeep Worah | 10 Jan 2015

In a blow to those suffering from lung and respiratory diseases, the Delhi High Court on Friday restrained domestic firm Cipla from marketing its affordable generic version of respiratory drug Onbrez, ruling in favour of multinational Novartis

Govt weighs options as court delays order on Novartis-Cipla patent dispute

19 Dec 2014

Delhi HC reserves order in Novartis-Cipla row over respiratory drug Onbrez

17 Dec 2014

Cipla wants Novartis’s patents on respiratory drug revoked

30 Oct 2014

Cipla, which launched a generic version of the drug, said Novartis imports "negligible quantity" of its patented drug Onbrez from Switzerland, thereby creating a supply shortage at a time when 15 million Indians needed treatment for chronic obstructive pulmonary disease

Cipla to invest Rs225 crore for setting up manufacturing unit in Iran

04 Oct 2014

Generic asthma inhaler drug breathes fresh life into Cipla

03 Sep 2014

Cipla to acquire 51% stake in Yemeni pharma firm

30 Jun 2014

Cipla buys 60% stake in Sri Lankan co in marketing push

17 Jun 2014

Cipla buys 14.6% stake in Chase Pharma to support Alzheimer treatment

12 May 2014

The disease costs the US alone $203 billion annually with projections to reach $1.2 trillion by 2050

Cipla chief Hamied calls for mechanism to make essential drugs affordable

05 May 2014

Cipla chairman Yusuf Hamied has long battled global pharmaceutical majors to ensure that the poor have access to life-saving drugs

Cipla launches first biosimilar drug for rheumatic disorders

17 Apr 2013

Cipla amends offer, offers $512 mn for whole of Cipla Medpro South Africa

28 Feb 2013

Cipla Ltd puts $220-mn bid for South African generic drug maker on hold

12 Feb 2013

Cipla appoints Novartis' Subhanu Saxena as new CEO

22 Nov 2012

Cipla has appointed the former CEO and country president of Novartis UK, Subhanu Saxena, as its new CEO

Cipla offers to acquire controlling stake in Cipla Medpro South Africa for $220 million

21 Nov 2012

View details about the software product Informachine News Trackers